Mesoblast R&D Spending Growth & History (MESO)
Mesoblast's r&d spending was $97.5M for fiscal 2026.
View full Mesoblast company overviewMesoblast annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-06-30 | $97.5M | $62.7M | +180.14% |
| 2025 | 2025-06-30 | $34.8M | −$4.9M | −12.36% |
| 2024 | 2024-06-30 | $39.7M | −$13.1M | −24.80% |
| 2023 | 2023-06-30 | $52.8M | $20.0M | +60.95% |
| 2022 | 2022-06-30 | $32.8M | −$20.2M | −38.10% |
| 2021 | 2021-06-30 | $53.0M | −$3.2M | −5.65% |
| 2020 | 2020-06-30 | $56.2M | −$3.6M | −6.06% |
| 2019 | 2019-06-30 | $59.8M | −$6.1M | −9.27% |
| 2018 | 2018-06-30 | $65.9M | $7.0M | +11.90% |
| 2017 | 2017-06-30 | $58.9M | $8.9M | +17.80% |
| 2016 | 2016-06-30 | $50.0M | — | — |
Mesoblast quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q3 2023 | 2023-03-31 | $7.1M | −$1.2M | −14.35% |
| Q1 2023 | 2022-09-30 | $5.7M | −$3.6M | −38.42% |
| Q3 2022 | 2022-03-31 | $8.3M | −$4.2M | −33.69% |
| Q1 2022 | 2021-09-30 | $9.3M | −$9.9M | −51.61% |
| Q3 2021 | 2021-03-31 | $12.4M | −$1.9M | −13.48% |
| Q1 2021 | 2020-09-30 | $19.3M | $6.9M | +55.61% |
| Q4 2020 | 2020-06-30 | $15.3M | $3.8M | +33.55% |
| Q3 2020 | 2020-03-31 | $14.4M | −$28,000 | −0.19% |
| Q2 2020 | 2019-12-31 | $14.2M | −$1.3M | −8.61% |
| Q1 2020 | 2019-09-30 | $12.4M | −$6.1M | −32.99% |
| Q4 2019 | 2019-06-30 | $11.4M | — | — |
| Q3 2019 | 2019-03-31 | $14.4M | −$2.4M | −14.23% |
| Q2 2019 | 2018-12-31 | $15.5M | −$734,000 | −4.52% |
| Q1 2019 | 2018-09-30 | $18.5M | — | — |
| Q3 2018 | 2018-03-31 | $16.8M | — | — |
| Q2 2018 | 2017-12-31 | $16.2M | — | — |
Mesoblast r&d spending trends
Over the last five fiscal years, Mesoblast's r&d spending increased from $53.0M to $97.5M, a change of $44.5M. The latest reported quarter, Q3 2023, shows $7.1M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Mesoblast source filings ↗